Breaking News, Promotions & Moves

Boehringer Appoints President of U.S. Fremont Biopharma Biz

Lars Dreesmann will lead the biopharmaceuticals development and manufacturing business.

By: Contract Pharma

Contract Pharma Staff

Boehringer Ingelheim has appointed Lars Dreesmann, Ph.D., as President of the company’s U.S. biopharmaceutical development and manufacturing business, Boehringer Ingelheim Fremont, Inc. Most recently, Dr. Dreesmann was Head of Global Quality Systems & Product Compliance Biopharma for Boehringer Ingelheim, a role he has held since January 2019. In his new role, Dr. Dreesmann will report to Jean-Michel Boers, U.S. Country Managing Director, President & CEO, Boehringer Ingelheim. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters